In summary, the current study presents persuasive evidence that the PD-1/PD-L1 pathway is deficient in the orbit of both TAO patients and healthy subjects, and explores the possibility of utilizing exogenous PD-L1 to reconstruct the orbital immune tolerance microenvironment in patients with TAO. Here, PDCD1 is linked to thromboangiitis obliterans.